Indian Journal of Clinical Biochemistry, 2010 / 25 (2)
Indian Journal of Clinical Biochemistry, 2010 / 25 (2) 182-187
ORIGINAL ARTICLE
EFFECTS OF GARLIC EXTRACT TREATMENT IN NORMAL AND STREPTOZOTOCIN
DIABETIC RATS INFECTED WITH CANDIDA ALBICANS
M Bokaeian, A Nakhaee*, Bita Moodi*, A Farhangi** and A Akbarzadeh**
Department of Laboratory Sciences, Faculty of Paramedical sciences, Zahedan University of Medical Sciences, Iran
*Department of Biochemistry, Faculty of Medicine, Zahedan University of Medical Sciences, Iran
**Department of Pilot Biotechnology, Pasteur institute of Iran, Tehran, Iran
ABSTRACT
The anti-candidial effect of garlic extract (Allium sativum L.) was investigated in normal and streptozotocininduced diabetic rats. Diabetes was induced after a single intraperitoneal injection of streptozotocin (60 mg/
kg). Rats were divided into six groups with fifteen rats in each group: (1) Normal control rats (2) Control rats +
C. albicans (3) Control rats + garlic extract + C. albicans (4) Diabetic control rats (5) Diabetic rats + C. albicans
(6) Diabetic rats + garlic extract + C. albicans. The concerned groups were inoculated with C.albicans on the
15 th day. At the end of one month experiment, fasted rats were killed by cervical decapitation. Blood was
collected for estimation of glucose and C. albicans concentrations were estimated in liver and kidneys
homogenates. A significant increase was observed in serum glucose levels in diabetic rats. A loss of bodyweight,
polydipsia and polyphagia were observed in diabetic rats. Administration of alcoholic extract of garlic (0.25 g/
kg body weight) reduced the hyperglycemia, polydipsia, polyphagia and associated weight loss of streptozotocintreated rats. Administration of garlic extract significantly reduced C. albicans concentrations in liver and kidneys
homogenates in infected control and diabetic rats. It is concluded that garlic extract improves candidia infection
in diabetic rats.
KEY WORDS
Garlic (Allium sativum L.), Streptozotocin induced-diabetic rats, Candida albicans.
INTRODUCTION
Diabetes mellitus comprises a group of chronic diseases
characterized by hyperglycemia or diminished insulin
secretion, or both (1). In the year 2004, according to the World
Health Organization reports, more than 150 million people
throughout the world suffered from diabetes (2) while the
mankind has been unable to solve this problem. Although
Address for Correspondence :
Dr. Azim Akbarzadeh
Pilot Biotechnology Department
Pasteur Institute of Iran
No. 358, 12 Farvardin Street, Jomhoori Avenue,
Tehran- Iran, 13169- 43551
Tel: + 98 21 6646 5406
E-mail: azimakbarzadeh@pasteur.ac.ir,
azimakbarzadeh@yahoo.com
182
present therapy for diabetes mellitus relies heavily on an
arsenal of drugs developed since the introduction of insulin
(3), prior to 1922 diabetes therapy revolved around dietary
measures including the use of traditional anti-hyperglycemic
plants(4). The World Health Organization has recommended
that traditional plant treatments for diabetes warrant further
evaluation (5). Many herbal medicines have been
recommended for the treatment of diabetes (6, 7). Plant drugs
are frequently considered to be less toxic and free from side
effects more than synthetic ones (8). Some studies confirmed
anti-hyperglycemic (9, 10) and anti-microbial (11-15) effects
of garlic.
In the current literature, there is a paucity of information
regarding the in-vivo anti-candidiasis efficacy of garlic extract.
Thus the purpose of the present study was to compare the
efficacy of garlic extract in treatment of established systemic
candidiasis in normal and diabetic rats.
Anti-Candidial Effect of Garlic Extract
MATERIALS AND METHODS
Chemicals: Streptozotocin was obtained from Sigma- Aldrich
(St Louis, MO, USA). All other chemicals were of the highest
purity available.
Animals: Ninety male Wistar rats, weighting 200-250 g, were
used in all experiments. Groups of rats were housed in an air
conditioned room at 22±2°C with a lighting schedule of 12 h
lighting and 12 h darkness. Animals had free access to a
standard pellet diet (Rat breeding diet, Pillsbury Ltd.,
Birmingham, UK) and tap water. The overall nutrient
composition of the diet was 36.2% carbohydrates, 20.9%
protein, 4.4% fat and 38.5% fiber with added vitamins and
minerals. Four rats were housed per cage. Permission for the
study was obtained from the government of Iran.
Preparation of garlic extract: Fresh garlic bulbs (A. sativum
L.) were purchased from a commercial source. Sliced, dried
and ground bulbs (100 g) were submitted to extraction with
300 ml ethanol (80%) in a Soxhlet apparatus for 72 h. After
extraction, the solvent was filtered and then evaporated by
Rotavapor. The obtained garlic extract was stored at -20°C
until being used.
Drug administration: Garlic extract was suspended in distilled
water and administered orally through orogastric tube at dose
0.25 g/kg body weight of rats (groups 3 and 6) 5 day before
and after intraperitoneal administration of streptozotocin. The
volume of administrated extract was 1 ml for each animal.
Microorganism: C. albicans (ATCC 10731) was cultured for
24 hours at 37°C on Sabouraud dextrose agar (SDA) then
stored at 4°C. The morphology and biochemical characteristics
of yeast cells were verified by microscopic observations,
colonial morphology on SDA, formation of germ tubes in
serum, formation of chlamydospores on chlamydospore agar,
and sugar fermentation reactions. For experiments, a single
stock was prepared with organisms that were grown on SDA
for 24 hours at 37°C, washed from the slants in 2 ml of sterile
saline at a concentration of 1×106 colony forming units (CFU)
ml-1. Rats in groups 2, 3, 5 and 6 were inoculated (day 15)
intraperitoneally with 0.2 ml of 105 CFU ml-1 suspension of
organism (16). Verification of the concentration was done using
serial Sabouraud dextrose pour plates of 10-fold dilutions of
the original suspension.
Experimental induction of diabetes: Rats in groups 4 to 6
were injected (day 5) with a freshly prepared solution of
streptozotocin (60 mg/kg body weight) in 0.1 mol/L sodium
citrate buffer (pH 4.5) (17). Control rats (groups 1 to 3) were
treated with the same amount of citrate buffer without
streptozotocin. The dosing volume was 1 ml /kg. Successful
induction of diabetes was confirmed by measuring the fasting
blood glucose concentration in rats 48 h after injection of
streptozotocin. Rats with fasting blood glucose levels over
180 mg/dl were defined as diabetic and included in the study.
The food and water were removed from cages 12 h before
testing.
Experimental design: In the present experiment, 90 rats (45
diabetic and 45 normal rats) were used. The rats were divided
into six groups, with fifteen rats in each group, as follows: (1)
Normal control rats were administrated with 1 ml of distilled
water (2) control rats were administrated with 1 ml of distilled
water and injected with C. albicans (3) control rats were
administrated with garlic extract (0.25 g/kg body weight) and
injected with C. albicans (4) diabetic control rats were
administrated with 1 ml of distilled water (5) diabetic rats were
administrated with 1 ml of distilled water and injected with C.
albicans (6) diabetic rats were administrated with garlic extract
(0.25 g/kg body weight) and injected with C. albicans. Daily
measures of body weight, food intake and water intake were
done. Postprandial blood samples obtained from the cut tail
tip of conscious rats were collected on days 15 and 30 for
serum glucose analysis.
Measurement of glucose in rats’ serum: One ml of blood
was taken from rats in order to measure glucose. The samples
were collected in sterilized tubes and kept at 4°C and after
separating the clot, the serum was separated by centrifuging.
Serum glucose was estimated by glucose oxidase
method (18).
Quantification of Candida in organs: After 30 days of
treatment, overnight-fasted rats were killed by cervical
decapitation. To quantitate Candida organism in organs, both
kidneys and liver were removed, rinsed of any adhering blood
and homogenized in 5 ml PBS (pH 7.2) in a motor-driven
Teflon-glass homogenizer (Glas-Col). Serial 200-fold dilutions
of the homogenates were plated (at 0.1 ml) on Petri dishes
containing Sabouraud agar, inverted and incubated for 48 h
at 37°C. The CFU per gram of tissue for each kidney and the
liver from each rat was converted to log 10 values for statistical
manipulation.
Statistical analysis: All data are expressed as the mean
±SEM for fifteen rats in each experimental group. Statistical
analysis was performed using SPSS 10.0 statistical software.
One-way analysis of variance (ANOVA) followed by the Tukey
183
Indian Journal of Clinical Biochemistry, 2010 / 25 (2)
Table 1: Effects of garlic extract administration on body weight, water intake, food intake and serum glucose
concentrations of normal and streptozotocin-treated rats
Normal
control rats
Control rats
+C. albicans
Control rats
+garlic extract
+C. albicans
Diabetic
control rats
Diabetic rats
+C. albicans
Diabetic rats
Between
+garlic extract groups sig.
+C. albicans
208.3±4.3
204.6±4.9
209.5±4.1
205.9±4.5
206.3±4.1
207.6±4.8
0.354
173.5±4.2
238.7±5.2c
0.042
31.3±2.9
33.8±2.3
0.490
0.009
Body weight (g)
Study Day 0
Study Day 30
330.7±4.4
321.4±6.3
323.2±5.5
178.2±4.6a
34.5±3.4
32.6±3.8
33.4±3.3
32.2±2.8b
Water intake (mL/day)
Study Day 0
Study Day 30
49.8±1.8
47.5±2.2
48.3±2.5
301.2±4.1
281.5±5.1
170.7±6.6 d
12.8±0.9
12.6±0.7
13.1±1.1
12.7±0.7
12.6±0.8
12.9±0.9
0.381
57.1±1.3
38.4±2.2 d
0.008
287.9±4.6
218.6±4.3c
0.045
Food intake (g/day)
Study Day 0
Study Day 30
22.3±0.5
21.3±0.9
22.9±0.7
60.2±1.6 a
110.3±3.1
112.3±2.8
111.9±2.6
296.3±4.8 a
Serum glucose (mg/dL)
Study Day 30
The values represent the mean± SEM for fifteen animals in each group. Comparisons were made by one-way ANOVA test. a P<0.05 compared to
normal control rats. b P<0.01 compared to normal control rats. c P<0.05 compared to diabetic control rats. d P<0.01 compared to diabetic control rats.
post hoc test was used to compare mean values of quantitative
variables among groups. The criterion for statistical
significance was P <0.05.
RESULTS
Bodyweight ,water and food intake, and serum glucose:
Tables 1 and 2 show significant differences in body weight,
water intake, food intake and serum glucose in the different
experimental groups.
Normal level of glucose in healthy adult rats was measured
as 110.3±3.1 mg dl-1. Daily consumptions of water and food
in healthy adult rats were measured as 49.8±1.8 ml and
22.3±0.5g respectively but in diabetic rats the level of glucose
was measured as 296.3±4.8 mg dl-1 and daily consumptions
of water and food were measured as 301.2±4.1 ml and
60.2±1.6g respectively. Compared with normal rats, rats
administered with streptozotocin showed a significant weight
loss (P=0.042: %13.4 decrease in percentage), polydipsia
(P=0.009: %835.4 increase in percentage) and hyperphagia
(P=0.008: %374.0 increase in percentage) by the end of the
study period. Administration of garlic extract reduced the weight
loss (P=0.04: %14.9 increase in percentage), polydipsia
(P=0.009: %405.0 increase in percentage) and hyperphagia
(P=0.008: %197.6 increase in percentage) associated with
streptozotocin treatment.
The results showed that serum glucose of diabetic rats
increased when compared with normal rats (P=0.045: %168.6
increase in percentage). Oral administration of the garlic
extract at dose of 0.25 g/kg body weight tended to bring serum
Table 2: Percentage* changes in body weight, water intake, food intake and serum glucose concentrations in
different experimental groups
Normal
control rats
Control rats
+C. albicans
Control rats
+garlic extract
+C. albicans
Diabetic
control rats
Diabetic rats
+C. albicans
Diabetic rats
Between
+garlic extract groups sig.
+C. albicans
Body weight (g)
+%58.7
+%57.0
+%54.2
-%13.4
+%15.8
+%14.9
0.042
Water intake (mL/day)
+%44.3
+%45.7
+%44.6
+%835.4
+%799.3
+%405.0
0.009
Food intake (g/day)
+%74.2
+%69.0
+%74.8
+%374.0
+%353.1
+%197.6
0.008
%0.0
+%1.8
+%1.4
+%168.6
+%161.0
+%98.1
0.045
Serum glucose (mg/dL)
-Negative numbers indicate decrease in percentage; +Positive numbers indicate increase in percentage; *Percentages indicate the differences
between first and thirtieth days in each group
184
Anti-Candidial Effect of Garlic Extract
glucose significantly (P=0.047: %98.1 increase in percentage)
toward normal values, while normal rats did not exhibit any
significant alteration in serum glucose level during the
experiment.
C. albicans in liver and kidneys homogenates: Table 3
shows the C. albicans content in liver and kidneys
homogenates for rats in different experimental groups. There
was a significant increase (P<0.01) in the concentration of
C. albicans in the liver and kidneys homogenates in diabetic
rats compared with control rats. Administration of garlic extract
significantly reduced Candida titers in the liver (P=0.009) and
kidneys (P=0.008) in both normal and diabetic rats compared
with the titer in the controls.
DISCUSSION
Diabetes mellitus is a highly prevalent chronic illness and a
major socio-economical burden with serious health
consequences. A study conducted by the World Health
Organization reported that the worldwide prevalence of
diabetes in 2002 was 170 million, with the number predicted
to grow to 366 million by 2030 (19).
We used streptozotocin for diabetes induction in the rats.
Streptozotocin is a commonly used compound for inducing
type1 diabetes in a variety of animals by affecting degeneration
and necrosis of pancreatic E-cells (20). Researchers around
the world have used streptozotocin to create experimental
diabetes because it is a simple, inexpensive and available
method (21, 22). Intra-venous or intra-peritoneal injection of
60 mg/kg dose of streptozotocin in adult wistar rats, makes
pancreas swell and at last causes degeneration in Langerhans
islet beta cells and induces experimental diabetes mellitus in
2-4 days (16, 23).
In the present study, consumptions of water and food increased
in diabetic animals in comparision with normal rats but body
weight decreased. These data are consistent with the findings
of Dhuley (16), Holemans et al (22) and Swanston –Flatt et al
(24 ) who found water and food increase and body weight
decrease in streptozotocin induced diabetes.
The present data indicated that the garlic extract significantly
decreased serum glucose levels in treated diabetic rats as
compared with control diabetic rats. In agreement with the
present results, several studies have shown the hypoglycemic
effect of garlic (9, 10, 25). The hypoglycemic potency of garlic
has been attributed mainly to allicin and its derived sulphur
compounds (10, 25).
In the present study, administration of garlic extract reduced
the weight loss, polydipsia and hyperphagia associated with
streptozotocin treatment. In consistent with present data, other
researchers have reported that administration of garlic extracts
prevented loss of body weight, polydipsia and hyperglycemia
of streptozotocin diabetic rats (9, 26). The dosage of garlic
extract in our study was 0.25 g/kg body weight. It has been
reported that the anti-diabetic beneficial effects of garlic extract
are prominent with a dosage of 0.25 g/kg body weight in
comparison with other dosages (26).
We used C. albicans for inducing systemic candidiasis in rats.
The model of candidiasis in rats used in the present experiment
is one of a sub-acute systemic infection that is usually well
tolerated by the animals for several weeks but is not cleared
spontaneously (16). This model, with treatment delayed for
several days, mimics human infection. This is unlike mouse
lethality studies, in which therapy is initiated concomitant with
injection of an otherwise lethal inoculum (16). In the present
study, there was an increase in the concentration of C. albicans
in the kidneys homogenates compared with the liver
homogenates in normal rats.
In the majority of experimentally induced systemic infections,
the kidneys of animals were the organ that bore the heaviest
foci of infections through out the experiments (27, 28). It is
unclear why kidneys are more susceptible to Candida
Table 3: C. albicans concentration in liver and kidneys homogenates for rats in different experimental groups
Normal
control rats
Control rats
+C. albicans
Control rats
+garlic extract
+C. albicans
Diabetic
control rats
Diabetic rats
+C. albicans
Diabetic rats
Between
+garlic extract groups sig.
+C. albicans
3.13±0.11
2.21±0.08 b
0.00±0.00
5.32±0.14 a
4.38±0.18 b
0.009
4.655±0.13
3.35±0.12 b
0.00±0.00
5.41±0.15 a
4.43±0.20b
0.008
`Mean log 10 CFU g-1 of tissue± SEM
Liver
Kidney *
0.00±0.00
0.00±0.00
*Mean for right and left kidneys. The values represent the mean± SEM for fifteen animals in each group.Comparisions were made by one-way
ANOVA test. a P<0.05 compared to control rats. b P<0.01 compared to control rats.
185
Indian Journal of Clinical Biochemistry, 2010 / 25 (2)
infections and it has been suggested that the physiological
conditions (28), anatomical architecture (29) and the poor
phagocytic system of kidneys (30, 31) may be contributing
factors for predisposition of kidneys to the long-term systemic
Candida infections.
Tsao et al (32) reported that methicillin-resistant
Staphylococcus aureus was markedly present in kidneys of
diabetic mice and Raffel et al (33) reported that the
inflammatory reaction in kidneys infected with C. albicans was
greater in diabetic rats and fungus balls associated with
ureteral obstruction and gross multiple renal abscesses
occurred in diabetic, but not in non-diabetic rats infected with
Candida. In the latter study, it has been reported that the renal
microbial populations of C. albicans were found to be greater
than 105 colony-forming units per g in diabetic rats, whereas
the kidneys tended to become sterile in non-diabetic rats (33).
In the present study, the concentrations of C. albicans in both
liver and kidneys homogenates of diabetic rats were high. It
has been shown in the normal individuals, a formidable barrier
to C. albicans is provided by a multitude of effectors and control
mechanisms (28, 29) but in diabetic patients, C. albicans
remains one of the organisms most frequently producing
infection (34).
Patients with diabetes mellitus have an increased susceptibility
to infections. In other studies, diabetic animals were more
susceptible to microbial infections than normal ones (16, 32,
33). Hepatic predisposition of experimental animals to Candida
infection reported previously (27, 28) is an effect which is
observed in the long-term infections and it has been suggested
that this predisposition could be due to recruitment of
premature monocytes and PMNs from bone marrow (35).
These cells contain greater numbers of abnormal giant
lysosomes which are defective in phagosome-lysosome fusion
process (35). This situation provides an opportunity for the
yeast to grow and produce infectious foci in liver. Yamashiro
et al (36) reported that in diabetic mice, the levels of IL-12
and IFN-gamma in liver were lower than those in control
animals on day 14 post-infection, while the opposite was true
for IL-4 levels. Treatment of normal and diabetic rats with garlic
extract after Candida inoculation caused a considerable
inhibitory effect on the growth of the organism in both liver
and kidneys.
Tsao et al (15, 32) reported that garlic extract and its two diallyl
sulphides (DAS and DADS) could effectively decrease
methicillin-resistant Staphylococcus aureus viability in blood
and organs in diabetic and non-diabetic mice. Bhagyalakshmi
186
et al (37) reported that oral administration of DAS or DADS
could effectively reduce methicillin-resistant Staphylococcus
aureus viability in kidney from 107 to 104 CFU g-1 in diabetic
mice.
Some in-vitro studies confirmed anti-bacterial (11, 15) and antiCandidal (12- 14) effects of garlic extract but there is a paucity
of information regarding the in-vivo anti-candidiasis efficacy
of garlic extract. Our findings indicate that garlic extract exhibits
inhibitory effects against candidiasis in both control and diabetic
rats. The anti-candidial effects of garlic attributed mainly to
allicin (38). Allicin, one of the active principles of freshly crushed
garlic homogenates, has a variety of anti-bacterial (against a
wide range of gram-negative and gram-positive bacteria),
antifungal (particularly against C. albicans), anti-parasitic and
anti-viral activities (38).
Some approaches suggest that garlic extract exerts its effect
by the oxidation of thiol groups present in the essential proteins,
causing inactivation of enzymes and subsequent microbial
growth inhibition (13). It has been also reported that blockage
of lipid synthesis (39), enhancement of phagocytosis and
increase in natural killer cell activity (40) may be important
components of the anti-candidal activity of garlic.
We used fresh garlic extract in our investigation. It has been
reported that the use of fresh garlic is more effective for antimicrobial activity than that from old garlic (11, 14).
These results indicate that garlic extract exhibits inhibitory
effects against candidiasis and therefore validates the
traditional use of the plant in fungal infections in diabetic
patients. In addition, further comprehensive pharmacological
investigations, including experimental chronic studies, should
be carried out.
ACKNOWLEDGEMENT
This work was funded, in part, by Research Center for
Infectious Disease and Tropical Medicine, Zahedan University
of Medical Sciences, Zahedan- Iran.
REFERENCES
1.
2.
3.
Baynes YW, Thorpe R. Role of oxidative stress in diabetic
complications. Diabetes 1999; 48: 1- 9.
World Health Organization; http:/www.who.int/medacenter/
factsheets/138/en/Page1-3.
Bailey CJ. Potential new treatments for type 2 diabetes. Trends
Pharmacol Sci 2000; 21: 259-65.
Anti-Candidial Effect of Garlic Extract
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
Gray AM, Flatt PR. Pancreatic and extra-pancreatic effects of the
traditional anti-diabetic plants, Medicago sativa (alfalfa). Brit J Nutr
1997; 78(2): 325-34.
World Health Organization Expert Committee on Diabetes Mellitus,
Second Report. Technical Report Series 646.World Health
Organization, Geneva 66; 1980.
Marles RJ, Farnsworth N. Antidiabetic plants and their active
constituents. Phytomedicine 1995; 2(2): 137-89.
Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S. Study
of the antihyperglycemic effect of plants used as antidiabetics. J
Ethnophamacol 1998; 61: 101- 10.
Pari L, Umamaheswari J. Antihyperglycaemic activity of Musa
sapientum flowers: effect on lipid peroxidation in alloxan diabetic
rats. Phytother Res 2000; 14: 1- 3.
Eidi A, Eidi M, Esmaeili E. Antidiabetic effects of garlic (Allium sativum
L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine
2006; 13(9-10): 624-29.
Mathew PT, Augusti KT. Studies on the effect of allicin (diallyl
disulphide-oxide) on alloxan diabetes: part I- hypoglycaemic action
and enhancement of serum insulin effect and glycogen synthesis.
Ind J Biochem Biophs 1973; 10: 209-12.
Sasaki J, Kita T, Ishita K, Uchisawa H, Matsue H. Antibacterial activity
of garlic powder against Escherichia coli O-157. J Nutr Sci Vitaminol
(Tokyo) 1999; 45(6): 785-90.
Vaijayanthimala J, Anandi C, Udhaya V, Pugalendi KV. Anticandidal
activity of certain South Indian medicinal plants. Phytother Res 2000;
14(3): 207-9.
Gannoum MA. Studies on the anticandidial mode of action of Allium
sativum (garlic). J Gen Microbiol 1988; 134(11): 2917-24.
Lemar KM, Turner MP, Lioyd D. Garlic (Allium sativum) as an antiCandida agent: a comparison of the efficacy of fresh garlic and
freeze-dried extracts. J Appl Microbiol 2002; 93(3): 398-405.
Tsao SM, Hsu CC, Yin MC. Garlic extract and diallyl sulphides inhibit
methicillin-resistant Staphylococcus aureus infection in BALB/cA
mice. J Antimicrob Chemother 2003; 52: 974-80.
Dhuley JN. Hamycin treatment of candidiasis in normal and diabetic
rats. FEMS Immunol Med Microbiol 1999; 26: 175-80.
Siddique O, Sun Y, Lin JC, Chien YW. Facilitated transdermal
transport of insulin. J Pharm Sci 1989; 76: 341-5.
Barham D, Trinder P. An improved color reagent for the determination
of blood glucose by the oxidase system. Analyst 1972; 142-5.
Wild S, Roglic G, Green A, King H. Global prevalence of diabetes:
Estimates for the year 2000 and projections for 2030. Diabetes Care
2004; 27: 1047-53.
Aksoy N, Vural H, Sabuncu T, Aksoy S. Effect of melatonin on
oxidative-antioxidative status of tissues in streptozotocin-induced
diabetic rats. Cell Biochem Funct 2003; 21: 121-5.
Thulesen J, Qrskov C, Holst JJ, Poulsen SS. Short term insulin
treatment prevents the diabetogenic action of streptozotocin in rats.
Endocrinol 1997; 138(1): 62-8.
Holemans K, Bree RV, Verhaeghe J, Meurrens K, Assche AV.
Maternal semi starvation and streptozotocin-diabetes in rats have
different effects on the in vivo glucose uptake by peripheral tissues
in their female adult offspring. J Nutr 1997; 127: 1371-6.
23. Weiss RB. Streptozotocin: A review of its pharmacology, efficacy
and toxicity. Cancer Treatment Report 1982; 66(3): 427-38.
24. Swanston –Flatt SK, Day CJ, Flatt PR. Traditional plant treatments
for diabetes: Studies in normal and streptozotocin diabetic mice.
Diabetologia 1990; 33: 462-4.
25. Chang MLW, Johnson MA. Effect of garlic on carbohydrate
metabolism and lipid synthesis in rats. J Nutr 1980; 110: 931-6.
26. Rajani Kanth V, Uma Maheswara Reddy P, Raju TN. Attenuation of
streptozotocin-induced oxidative stress in hepatic and intestinal
tissues of wistar rat by methanolic-garlic extract. Acta Diabetol 2008;
45(4): 243-51.
27. Baghian A, Lee KW. Systemic candidosis. J Leuk Biol 1988; 44:
166-71.
28. Baghian A, Lee KW. Role of activated macrophages in resistance
to systemic candidosis in beige mice. J Med Vet Mycol 1989; 27:
51-5.
29. Giger DK, Domer JE, Moser SA, McQuitty JT. Experimental murine
candidiasis: Pathological and immune responses in T lymphocyte
depleted mice. Infect Immun 1978; 21: 729-37.
30. Louria DB, Brayton RG, Finkel G. Studies on the pathogenesis of
experimental Candida albicans infections in mice (abstract).
Sabouraudia 1963; 2: 271.
31. Winblad B. Experimental renal candidiasis in mice and guinea pigs.
Acta Pathol Microbiol Scan (Section A) 1975; 83: 406-14.
32. Tsao SM, Hsu CC, Yin MC. Meticillin-resistant Staphylococcus
aureus infection in diabetic mice enhanced inflammation and
coagulation. J Med Microbiol 2006; 55: 379-85.
33. Raffel L, Pitsakis P, Levison SP, Levison ME. Experimental Candida
albicans, Staphylococcus aureus and Streptococcus faecalis
pyelonephritis in diabetic rats. Infect Immun 1981; 34(3): 773-9.
34. Fraser VJ, Jones M, Dunkel J, Storter S, Mcdoff G, Dunagan WC.
Candidemia in a tertiary care hospital: epidemiology, risk factors
and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.
35. Baghian A, Lee KW. Elimination of Candida albicans from kidneys
of mice during short-term systemic infections. Kidney Int 1991; 40:
400-405.
36. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K,
Saito A. Lower expression of Th1-related cytokines and inducible
nitric oxide synthase in mice with streptozotocin-induced diabetes
mellitus infected with Mycbacterium tuberculosis. Clin Exp Immunol
2005; 139(1): 57-64.
37. Bhagyalakshmi N, Thimmaraju R, Venkatachalam L, Chidambara
Murthy KN, Sreedhar RV. Nutraceutical applications of garlic and
the intervention of biotechnology. Critical Reviews in Food Science
and Nutrition 2005; 45(7-8): 607-21.
38. Ankari S, Mirelman D. Antimicrobial properties of allicin from garlic.
Microbes and Infection 1999; 1(2): 125-9.
39. Adetumbi M, Javor GT, Lau BH. Allium sativum (garlic) inhibits lipid
synthesis by Candida albicans. Antimicrob Agents Chemother 1986;
30(3): 499-501.
40. Kyo E, Uda N, Kakimoto M, Yokoyama K, Ushijima M, Sumioka I,
Kasuga S, Itakura Y. Anti-allergic effects of aged garlic extract.
Phytomedicine 1997; 4: 335-40.
187